Psilocybin Causes ‘Significant Reduction’ in Symptoms of Depression, Largest of its Kind Study Shows

High Times
By Benjamin M. AdamsMay 24, 2022, 4:39 pm323 pts
At the American Psychiatric Association (APA) 2022 Annual Meeting that began on May 21 in New Orleans, Louisiana, COMPASS Pathways unveiled the “largest randomized, controlled, double-blind study of psilocybin therapy ever completed,” according to a May 24 press release, and the data shows “significant”…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Audit Finds Noncompliance by Alabama Medical Cannabis Commission 77

New Mexico Lawmaker Celebrates New Funding To Provide Psilocybin Therapy Access For Low-Income Patients 76

Georgia Lawmakers Pass Bill To Expand Medical Marijuana Access, Sending It To Governor’s Desk 70

NJ Senate Passes Infused Hemp Phased-In Ban Changes 63

Jersey City Leads Cracks Down on Weed Smoke Shops 54

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.